LYTLE PAUL J 4
4 · PEREGRINE PHARMACEUTICALS INC · Filed Feb 21, 2012
Insider Transaction Report
Form 4
LYTLE PAUL J
Chief Financial Officer
Transactions
- Award
Incentive Stock Options (right to buy)
2012-02-17+140,000→ 407,500 totalExercise: $0.95From: 2012-05-17Exp: 2022-02-17→ Common Stock (140,000 underlying)
Footnotes (1)
- [F1]This option vests quarterly over a two year period.